Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia [Phase 2]
Phase 2 dose-ranging study evaluating magnesium iron hydroxycarbonate for hyperphosphataemia in haemodialysis patients; study completed.
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: An Evaluation of the Long-term Safety of Magnesium Iron Hydroxycarbonate [Phase 2]
Phase 2 study evaluating the long-term safety of magnesium iron hydroxycarbonate in chronic kidney disease was terminated.
-
CLINICAL_TRIALS research · 2009-07-28Clinical Trial Update: Effect of Obstructive Sleep Apnea on Central Blood Pressure and Kidney and Endothelial Function [NA]
This clinical trial update describes a study evaluating the impact of obstructive sleep apnea on central blood pressure, kidney function, an…
-
CLINICAL_TRIALS trial_result · 2009-07-14Clinical Trial Update: Tryptophan Metabolism in Kidney Disease
A clinical trial evaluating tryptophan metabolism in chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2009-07-10Clinical Trial Update: Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis [Phase 3]
Amgen's Phase 3 trial in subjects with chronic kidney disease not receiving dialysis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-07-09Clinical Trial Update: Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT) [Phase 2]
A Phase 2 clinical trial evaluating tocopherols (vitamin E) and alpha-lipoic acid for chronic kidney disease has completed (TALAT).
-
FDA approval · 2009-06-30FDA Approved: FERAHEME — Original Application (AMAG Pharmaceuticals, Inc.)
The FDA approved Feraheme (ferumoxytol) from AMAG Pharmaceuticals as an original application for the treatment of iron deficiency anemia in …
-
FDA approval · 2009-06-29FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for ZEMPLAR (paricalcitol) by AbbVie Inc.
-
CLINICAL_TRIALS trial_result · 2009-06-03Clinical Trial Update: Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation [NA]
A clinical trial evaluating paricalcitol for protective effects on the inner vessel layer and anti-inflammatory activity in chronic kidney d…
-
CLINICAL_TRIALS trial_result · 2009-06-03Clinical Trial Update: Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria [Phase 4]
Phase 4 trial update assessing the effect of renin-angiotensin system blockade on Fas (CD95) and asymmetric dimethylarginine (ADMA) levels i…
-
CLINICAL_TRIALS trial_result · 2009-05-22Clinical Trial Update: Fixed Dose NESP Study in Subjects With CRI [Phase 2]
Amgen completed a Phase 2 fixed-dose study of NESP in subjects with chronic kidney disease not yet on dialysis (pre-dialysis).
-
CLINICAL_TRIALS trial_result · 2009-05-22Clinical Trial Update: Phase 2 Study of Darbepoetin Alfa Extended Dosing [Phase 2]
A Phase 2 study evaluating extended dosing of darbepoetin alfa for anemia in pre-dialysis chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2009-05-22Clinical Trial Update: Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis [Phase 3]
A Phase 3 study evaluating darbepoetin alfa in subjects with chronic kidney disease receiving dialysis has completed.
-
CLINICAL_TRIALS trial_result · 2009-05-22Clinical Trial Update: A Proof-of-Concept Study of Darbepoetin Alfa in Partial Correction of Anemia in Chinese With Diabetic Nephropathy [NA]
This trial update reports the termination of a proof-of-concept study evaluating darbepoetin alfa for partial correction of anemia in Chines…
-
CLINICAL_TRIALS trial_result · 2009-05-14Clinical Trial Update: A Study of NeoRecormon in Patients With Chronic Kidney Disease. [Phase 4]
Phase 4 study of NeoRecormon in patients with chronic kidney disease evaluating anemia management has completed.
-
FDA approval · 2009-05-04FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for furosemide submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS research · 2009-04-28Clinical Trial Update: Ezetimibe/Simvastatin Combination in Proteinuric Nephropathy [Phase 4]
Phase 4 clinical trial evaluating the ezetimibe/simvastatin combination in patients with proteinuric nephropathy. The conditions included ar…
-
CLINICAL_TRIALS trial_result · 2009-04-15Clinical Trial Update: Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation [Phase 4]
A completed Phase 4 study evaluating tacrolimus as immunosuppressive therapy after kidney transplantation.
-
CLINICAL_TRIALS trial_result · 2009-04-15Clinical Trial Update: Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney Disease [Phase 3]
Phase 3 trial evaluating whether N-acetylcysteine affects creatinine levels in chronic kidney disease; the study has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-08Clinical Trial Update: Evaluation of a Bioimpedance Method for Determination of Dry Weight in Dialysis Patients [NA]
The study evaluated a bioimpedance method to determine dry weight in dialysis patients; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects [NA]
Trial evaluating cholecalciferol (vitamin D3) therapy in chronic kidney disease patients with vitamin D deficiency has completed and results…
-
CLINICAL_TRIALS trial_result · 2009-03-09Clinical Trial Update: The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent Proteinuria [Phase 4]
This clinical trial update reports on changes in urinary angiotensinogen excretion after valsartan treatment in patients with persistent pro…
-
CLINICAL_TRIALS trial_result · 2009-03-05Clinical Trial Update: The Interrelation of the Vasculature, Endothelium, Bone Metabolism and Uremic Toxins in Peritoneal Dialysis
This completed clinical trial investigated the interrelations among vasculature, endothelium, bone metabolism, and uremic toxins in patients…
-
CLINICAL_TRIALS trial_result · 2009-02-13Clinical Trial Update: START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism [Phase 4]
Phase 4 trial evaluating a Sensipar (cinacalcet) treatment algorithm to reach K/DOQI targets in chronic kidney disease patients with seconda…
-
CLINICAL_TRIALS research · 2009-02-13Clinical Trial Update: Fluid Intake in Kidney Failure [NA]
A completed clinical trial from Medical University of Vienna investigated fluid intake in patients with chronic kidney disease and those wit…